Fortress Biotech Inc Pref Series A (FBIOP) financials · rev $63.3M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Fortress Biotech Inc Pref Series A (FBIOP) rev $63.3M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $63.3M | $57.7M |
| Cost of Revenue | $20.9M | $20.9M |
| Gross Profit | $42.3M | $36.8M |
| Operating Income | -$70.2M | -$110.4M |
| Net Income | $6.82M | -$46.0M |
| EPS (Diluted) | -$0.07 | -$2.69 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $185.5M | $144.2M |
| Current Assets | $123.8M | $90.4M |
| Cash & Equivalents | $79.4M | $57.3M |
| Inventory | $9.62M | $14.4M |
| PP&E | $2.52M | $3.26M |
| Total Liabilities | $123.4M | $145.9M |
| Current Liabilities | $49.7M | $71.4M |
| Long-term Debt | $52.4M | $58.0M |
| Total Debt | $52.4M† | $58.0M† |
| Shareholders' Equity | $49.9M | $22.7M |
| Retained Earnings | -$734.1M | -$740.9M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$65.8M | -$80.2M |
| CapEx | N/A | N/A |
| Investing Cash Flow | $10.1M | -$15.0M |
| Financing Cash Flow | $77.4M | $70.6M |
| Dividends Paid | $664.0K | $694.0K |
| Net Change in Cash | $21.8M | -$24.6M |
| Free Cash Flow | N/A | -$80.2M |
FAQ
What is FBIOP P/E and revenue?
Fortress Biotech Inc Pref Series A (FBIOP) rev $63.3M.
What is FBIOP revenue?
Fortress Biotech Inc Pref Series A last cached revenue is $63.3M (FY2025).
Is FBIOP profitable?
Fortress Biotech Inc Pref Series A last cached net income is $6.82M (FY2025).
What are FBIOP total assets?
Fortress Biotech Inc Pref Series A last cached total assets are $185.5M (FY2025).
What is FBIOP free cash flow?
No cached cash-flow row for FBIOP yet.
Not investment advice. Cached statements, not a live tape.